Thai PainPREDICT Validation Study
Recruiting · NCT07195045 · Interventional (participants receive a specific treatment) · Lead sponsor: Chulalongkorn University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Early identification of PDN is crucial for timely treatment, prevention of complications such as foot ulcers and amputations, and for reducing healthcare costs. However, in Thailand there are limited culturally adapted and validated tools for screening PDN. PainPREDICT is an internationally validated questionnaire designed to characterize neuropathic pain profiles, but its adaptation for Thai patients has not yet been undertaken. In parallel, the use of mobile health technologies (mHealth) has the potential to expand access to screening and monitoring of chronic conditions, particularly in resource-limited settings.
Who can take part
Inclusion criteria
- Adults aged 18 years or older.
- Diagnosed with type 1 diabetes mellitus or type 2 diabetes mellitus.
- Able to communicate in Thai.
- Willing and able to provide written informed consent.
Exclusion criteria
- Presence of neuropathy due to other causes (e.g., alcohol, chemotherapy, HIV, other systemic diseases).
- Significant cognitive impairment or neurological conditions that prevent comprehension of the questionnaire.
- Severe psychiatric illness that interferes with study participation.
Where it is running
1 location listed.
- King Chulalongkorn Memorial hospital, The Thai Red Cross Society - Pathum Wan, Bangkok, Thailand